ARTICLE | Company News
Crescendo grants Zai rights to psoriasis antibody
May 30, 2018 6:43 PM UTC
Crescendo Biologics Ltd. (Cambridge, U.K.) granted Zai Lab Ltd. (NASDAQ:ZLAB) exclusive, worldwide rights to an undisclosed antibody based on its Humabody platform.
Crescendo received an upfront payment and is eligible for milestones and royalties. Zai and Crescendo each declined to discuss financial terms or details about the antibody...
BCIQ Target Profiles